Table 1. PSD95 Monoclonal Antibody Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. PSD95 Monoclonal Antibody Market Restraints

Table 3. PSD95 Monoclonal Antibody Market Trends

Table 4. PSD95 Monoclonal Antibody Industry Policy

Table 5. Global PSD95 Monoclonal Antibody Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 6. Global PSD95 Monoclonal Antibody Revenue Share by Company, 2019-2024, Ranked by Data of 2024

Table 7. Global PSD95 Monoclonal Antibody Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 8. Global PSD95 Monoclonal Antibody Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 9. Global PSD95 Monoclonal Antibody Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global PSD95 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global PSD95 Monoclonal Antibody Mergers & Acquisitions, Expansion Plans

Table 12. Global PSD95 Monoclonal Antibody Manufacturers Product Type

Table 13. Head Office and PSD95 Monoclonal Antibody Production Site of Key Manufacturer

Table 14. PSD95 Monoclonal Antibody Capacity of Major Manufacturers and Future Plan

Table 15. China PSD95 Monoclonal Antibody Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 16. China PSD95 Monoclonal Antibody Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 17. China PSD95 Monoclonal Antibody Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 18. Global PSD95 Monoclonal Antibody Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global PSD95 Monoclonal Antibody Production by Region, 2019-2024, (K Units)

Table 20. Global PSD95 Monoclonal Antibody Production Forecast by Region, 2024-2030, (K Units)

Table 21. Global Key Players of PSD95 Monoclonal Antibody Upstream (Raw Materials)

Table 22. Global PSD95 Monoclonal Antibody Typical Customers

Table 23. PSD95 Monoclonal Antibody Typical Distributors

Table 24. By Type, Global PSD95 Monoclonal Antibody Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global PSD95 Monoclonal Antibody Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global PSD95 Monoclonal Antibody Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global PSD95 Monoclonal Antibody Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global PSD95 Monoclonal Antibody Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global PSD95 Monoclonal Antibody Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global PSD95 Monoclonal Antibody Consumption Value Market Share, 2019-2030

Table 32. By Country, Global PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global PSD95 Monoclonal Antibody Sales Quantity Market Share, 2019-2030

Table 34. Sino Biological, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 35. Sino Biological, Inc. PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 36. Sino Biological, Inc. PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Sino Biological, Inc. Company Profile and Main Business

Table 38. Sino Biological, Inc. Recent Developments

Table 39. Cell Signaling Technology, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 40. Cell Signaling Technology, Inc. PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 41. Cell Signaling Technology, Inc. PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Cell Signaling Technology, Inc. Company Profile and Main Business

Table 43. Cell Signaling Technology, Inc. Recent Developments

Table 44. Bio-Techne Company Information, Head Office, Market Area, and Industry Position

Table 45. Bio-Techne PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 46. Bio-Techne PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Bio-Techne Company Profile and Main Business

Table 48. Bio-Techne Recent Developments

Table 49. OriGene Technologies, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 50. OriGene Technologies, Inc. PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 51. OriGene Technologies, Inc. PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. OriGene Technologies, Inc. Company Profile and Main Business

Table 53. OriGene Technologies, Inc. Recent Developments

Table 54. LifeSpan BioSciences, Inc Company Information, Head Office, Market Area, and Industry Position

Table 55. LifeSpan BioSciences, Inc PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 56. LifeSpan BioSciences, Inc PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. LifeSpan BioSciences, Inc Company Profile and Main Business

Table 58. LifeSpan BioSciences, Inc Recent Developments

Table 59. Abbexa Company Information, Head Office, Market Area, and Industry Position

Table 60. Abbexa PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 61. Abbexa PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Abbexa Company Profile and Main Business

Table 63. Abbexa Recent Developments

Table 64. MyBiosource, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 65. MyBiosource, Inc. PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 66. MyBiosource, Inc. PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. MyBiosource, Inc. Company Profile and Main Business

Table 68. MyBiosource, Inc. Recent Developments

Table 69. Biorbyt Company Information, Head Office, Market Area, and Industry Position

Table 70. Biorbyt PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 71. Biorbyt PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Biorbyt Company Profile and Main Business

Table 73. Biorbyt Recent Developments

Table 74. Creative Biolabs Company Information, Head Office, Market Area, and Industry Position

Table 75. Creative Biolabs PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 76. Creative Biolabs PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Creative Biolabs Company Profile and Main Business

Table 78. Creative Biolabs Recent Developments

Table 79. Assay Genie Company Information, Head Office, Market Area, and Industry Position

Table 80. Assay Genie PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 81. Assay Genie PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Assay Genie Company Profile and Main Business

Table 83. Assay Genie Recent Developments

Table 84. RayBiotech, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 85. RayBiotech, Inc. PSD95 Monoclonal Antibody Models, Specifications, and Application

Table 86. RayBiotech, Inc. PSD95 Monoclonal Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. RayBiotech, Inc. Company Profile and Main Business

Table 88. RayBiotech, Inc. Recent Developments

List of Figures

Figure 1. PSD95 Monoclonal Antibody Picture

Figure 2. Global PSD95 Monoclonal Antibody Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global PSD95 Monoclonal Antibody Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global PSD95 Monoclonal Antibody Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China PSD95 Monoclonal Antibody Consumption Value, (US$ million) & (2019-2030)

Figure 6. China PSD95 Monoclonal Antibody Sales Quantity (K Units) & (2019-2030)

Figure 7. China PSD95 Monoclonal Antibody Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China PSD95 Monoclonal Antibody Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China PSD95 Monoclonal Antibody Market Share of Global, 2019-2030

Figure 10. Global PSD95 Monoclonal Antibody Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China PSD95 Monoclonal Antibody Key Participants, Market Share, 2024

Figure 12. Global PSD95 Monoclonal Antibody Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global PSD95 Monoclonal Antibody Capacity Market Share by Region, 2024 VS 2030

Figure 14. Global PSD95 Monoclonal Antibody Production Market Share & Forecast by Region, 2019-2030

Figure 15. PSD95 Monoclonal Antibody Industry Chain

Figure 16. PSD95 Monoclonal Antibody Procurement Model

Figure 17. PSD95 Monoclonal Antibody Sales Model

Figure 18. PSD95 Monoclonal Antibody Sales Channels, Direct Sales, and Distribution

Figure 19. Recombinant

Figure 20. Non-recombinant

Figure 21. By Type, Global PSD95 Monoclonal Antibody Consumption Value, 2019-2030, US$ Million

Figure 22. By Type, Global PSD95 Monoclonal Antibody Consumption Value Market Share, 2019-2030

Figure 23. By Type, Global PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 24. By Type, Global PSD95 Monoclonal Antibody Sales Quantity Market Share, 2019-2030

Figure 25. By Type, Global PSD95 Monoclonal Antibody Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 26. Flow Cytometry

Figure 27. ELISA

Figure 28. Western Blot

Figure 29. Immunoprecipitation

Figure 30. Immunofluorescence

Figure 31. Other

Figure 32. By Application, Global PSD95 Monoclonal Antibody Consumption Value, 2019-2030, US$ Million

Figure 33. By Application, Global PSD95 Monoclonal Antibody Consumption Value Market Share, 2019-2030

Figure 34. By Application, Global PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 35. By Application, Global PSD95 Monoclonal Antibody Sales Quantity Market Share, 2019-2030

Figure 36. By Application, Global PSD95 Monoclonal Antibody Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 37. By Region, Global PSD95 Monoclonal Antibody Consumption Value Market Share, 2019-2030

Figure 38. By Region, Global PSD95 Monoclonal Antibody Sales Quantity Market Share, 2019-2030

Figure 39. North America PSD95 Monoclonal Antibody Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, North America PSD95 Monoclonal Antibody Consumption Value Market Share, 2024

Figure 41. Europe PSD95 Monoclonal Antibody Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, Europe PSD95 Monoclonal Antibody Consumption Value Market Share, 2024

Figure 43. Asia Pacific PSD95 Monoclonal Antibody Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country/Region, Asia Pacific PSD95 Monoclonal Antibody Consumption Value Market Share, 2024

Figure 45. South America PSD95 Monoclonal Antibody Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. By Country, South America PSD95 Monoclonal Antibody Consumption Value Market Share, 2024

Figure 47. Middle East & Africa PSD95 Monoclonal Antibody Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 48. U.S. PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 49. By Type, U.S. PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 50. By Application, U.S. PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 51. Europe PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 52. By Type, Europe PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 53. By Application, Europe PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 54. China PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 55. By Type, China PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 56. By Application, China PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 57. Japan PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 58. By Type, Japan PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 59. By Application, Japan PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 60. South Korea PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 61. By Type, South Korea PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 62. By Application, South Korea PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 63. Southeast Asia PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 64. By Type, Southeast Asia PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 65. By Application, Southeast Asia PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 66. India PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 67. By Type, India PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 68. By Application, India PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 69. Middle East & Africa PSD95 Monoclonal Antibody Sales Quantity, 2019-2030, (K Units)

Figure 70. By Type, Middle East & Africa PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 71. By Application, Middle East & Africa PSD95 Monoclonal Antibody Sales Quantity Market Share, 2024 VS 2030

Figure 72. Research Methodology

Figure 73. Breakdown of Primary Interviews

Figure 74. Bottom-up and Top-down Approaches

Figure 75. Top-down Approaches